U.S. News

Actions

Drug company representative collapses during Oval Office event

White House announcement on the popular weight-loss drug GLP-1
Commerce Secretary Howard Lutnick, from left, President Donald Trump, David Moore, president of Novo Nordisk Inc., Novo Nordisk President and CEO Mike Doustdar and Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, look on after a person collapsed during an event about drug prices, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington.
Posted
and last updated

A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President Donald Trump was discussing efforts to lower the cost of GLP-1 medications.

The event focused on new agreements with Eli Lilly and Novo Nordisk. During the remarks, the man collapsed. Several people, including Dr. Mehmet Oz, helped guide him safely to the floor.

RELATED STORY | Trump announces effort to lower cost and expand coverage for weight-loss drugs

The name of the individual who fainted has not been released. But before the video feed was cut, a voice could be heard saying, “Gordon, are you OK?”

In a statement, the White House said, "The gentleman is okay."

Oz was at the event in his official capacity as administrator of the Centers for Medicare & Medicaid Services.